Artiva Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 9.85 M | $42.27 M | 0.00% | 40.25% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 2.35 M | $10.10 M | 0.00% | 9.61% |
| VR ADVISER, LLC | 02/17/2026 | 1.61 M | $6.91 M | 0.00% | 6.57% |
| VENBIO PARTNERS LLC | 02/17/2026 | 648.51 K | $2.78 M | -43.56% | 2.65% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 520.33 K | $2.23 M | 0.00% | 2.13% |
| REVELATION CAPITAL MANAGEMENT, LLC | 02/17/2026 | 299.31 K | $1.28 M | 100.00% | 1.22% |
| VANGUARD GROUP INC | 01/29/2026 | 246.01 K | $1.06 M | 54.61% | 1.00% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 217.10 K | $931.35 K | -17.19% | 0.89% |
| BLACKROCK, INC. | 02/12/2026 | 212.54 K | $911.79 K | -27.81% | 0.87% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 194.11 K | $832.72 K | 0.00% | 0.79% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 144.86 K | $621.47 K | 611.37% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 116.20 K | $498.50 K | 46.82% | 0.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 101.12 K | $434.13 K | -8.82% | 0.41% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 100.00 K | $429.00 K | 0.00% | 0.41% |
| MARSHALL WACE, LLP | 02/13/2026 | 79.56 K | $341.31 K | 100.00% | 0.33% |
| JANE STREET GROUP, LLC | 02/12/2026 | 40.67 K | $174.48 K | 100.00% | 0.17% |
| UBS GROUP AG | 01/29/2026 | 36.87 K | $158.19 K | 74.40% | 0.15% |
| STATE STREET CORP | 02/13/2026 | 35.82 K | $153.69 K | -40.12% | 0.15% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 35.00 K | $150.15 K | 0.00% | 0.14% |
| SCIENTECH RESEARCH LLC | 02/17/2026 | 27.76 K | $119.08 K | 100.00% | 0.11% |
| MORGAN STANLEY | 02/13/2026 | 27.07 K | $116.14 K | -36.79% | 0.11% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 21.10 K | $90.52 K | 100.00% | 0.09% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 12.06 K | $51.74 K | -75.77% | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 10.69 K | $45.86 K | -25.25% | 0.04% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 5.49 K | $23.56 K | 0.00% | 0.02% |
| FMR LLC | 02/17/2026 | 3.56 K | $15.26 K | -27.68% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.50 K | $6.44 K | -11.76% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.10 K | $4.73 K | -88.95% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 542 | $2.33 K | -99.54% | 0.00% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 02/12/2026 | 400 | $1.72 K | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 339 | $1.00 K | -59.64% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 187 | $802 | -95.33% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 113 | $484 | -99.30% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 32 | $137 | 100.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/26/2026 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/29/2026 | 0 | $0 | -100.00% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 01/27/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Artiva Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Artiva Biotherapeutics Inc. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 39,496
VANGUARD FIDUCIARY TRUST CO: 32,810
Simplify Asset Management Inc.: 23,230
Sanctuary Advisors, LLC: 21,581
BAILARD, INC.: 20,700
DIMENSIONAL FUND ADVISORS LP: 20,370
69.26% of Artiva Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 17.06 M shares in the last 24 months. This purchase volume represents approximately $97.41 M in transactions.